A 3D human adipose tissue model within a microfluidic device. Issue 2 (22nd December 2020)

• Record Type: Journal Article
• Authors: Yang, Feipeng; Carmona, Alanis; Stojkova, Katerina; Garcia Huitron, Eric Ivan; Goddi, Anna; Bhushan, Abhinav; Cohen, Ronald N.; Brey, Eric M.
• Is Part Of: Lab on a chip. Volume 21:Issue 2(2021)
• Page Start: 435
• Page End: 446
• Publication Date: 2020-12-22
• Subjects: Miniature electronic equipment -- Periodicals; Combinatorial chemistry -- Periodicals; Biotechnology -- Periodicals; 543.0813
• DOI: 10.1039/d0lc00981d
• Languages: English
• ISSNs: 1473-0197

Abstract

Abstract : This work presents a microfluidic system for the engineering and analysis of 3D human adipose tissue under controlled flow. Abstract : An accurate in vitro model of human adipose tissue could assist in the study of adipocyte function and allow for better tools for screening new therapeutic compounds. Cell culture models on two-dimensional surfaces fall short of mimicking the three-dimensional in vivo adipose environment, while three-dimensional culture models are often unable to support long-term cell culture due, in part, to insufficient mass transport. Microfluidic systems have been explored for adipose tissue models. However, current systems have primarily focused on 2D cultured adipocytes. In this work, a 3D human adipose microtissue was engineered within a microfluidic system. Human adipose-derived stem cells (ADSCs) were used as the cell source for generating differentiated adipocytes. The ADSCs differentiated within the microfluidic system formed a dense lipid-loaded mass with the expression of adipose tissue genetic markers. Engineered adipose tissue showed a decreased adiponectin secretion and increased free fatty acid secretion with increasing shear stress. Adipogenesis markers were downregulated with increasing shear stress. Overall, this microfluidic system enables the on-chip differentiation and development of a functional 3D human adipose microtissue supported by the interstitial flow. This system could potentially serve as a platform for in vitro drug testing for adipose tissue-related diseases.